<DOC>
	<DOCNO>NCT00722202</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics IV administer ERB-257 single ascending dos healthy Japanese male subject</brief_summary>
	<brief_title>Study Evaluating Safety Pharmacokinetics ( PK ) Ascending Single IV Doses ERB-257 Healthy Japanese Males</brief_title>
	<detailed_description />
	<criteria>1 . Healthy Japanese men age 20 50 . 2 . Body mass index ( BMI ) range 17.6 26.4 kg/m2 body weight great equal 45 kg2 . 3 . Have high probability compliance completion study . 1 . Presence history disorder may prevent successful completion study . 2 . Acute disease state ( eg , nausea , vomit , infection , fever , diarrhea ) within 7 day study day 1 .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>